This summary was created by AI, based on 1 opinions in the last 12 months.
Experts agree that the Middlefield Healthcare Dividend ETF, with symbol MHCD-T, is an active fund with higher fees compared to typical ETFs. The management expense ratio (MER) is around 1%, which is considered high, especially when there are lower-cost index tracking solutions available. They advise cost-sensitive investors to consider alternatives and approach this stock with caution due to its high MER.
Middlefield Healthcare Dividend ETF is a Canadian stock, trading under the symbol MHCD-T on the Toronto Stock Exchange (MHCD-CT). It is usually referred to as TSX:MHCD or MHCD-T
In the last year, 1 stock analyst published opinions about MHCD-T. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Middlefield Healthcare Dividend ETF.
Middlefield Healthcare Dividend ETF was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Middlefield Healthcare Dividend ETF.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year, there was no coverage of Middlefield Healthcare Dividend ETF published on Stockchase.
On 2024-12-05, Middlefield Healthcare Dividend ETF (MHCD-T) stock closed at a price of $11.82.
Because they're active, fees are also higher than a typical ETF. MER is somewhere in the 1% range, which doesn't sound like a headwind, but there are many that are much cheaper. If you're a cost-sensitive investor, he'd encourage you to investigate index tracking solutions.
High MER means it should be more of an exploratory position, be careful of position size.